دورية أكاديمية

Phase II Study to Evaluate the Safety and Efficacy of the Oral Neurokinin-1 Receptor Antagonist Casopitant (GW679769) Administered with Ondansetron for the Prevention of Postoperative and Postdischarge Nausea and Vomiting in High-risk Patients.

التفاصيل البيبلوغرافية
العنوان: Phase II Study to Evaluate the Safety and Efficacy of the Oral Neurokinin-1 Receptor Antagonist Casopitant (GW679769) Administered with Ondansetron for the Prevention of Postoperative and Postdischarge Nausea and Vomiting in High-risk Patients.
المؤلفون: Singla, Nell K., Singla, Sonia K., Chung, Frances, Kutsogiannis, Demetrios J., Blackburn, Linda, Lane, Stephen R., Levin, Jeremey, Johnson, Brendan, Pergolizzi Jr., Joseph V.
المصدر: Anesthesiology; Jul2010, Vol. 113 Issue 1, p74-82, 9p, 3 Charts, 5 Graphs
قاعدة البيانات: Complementary Index
الوصف
تدمد:00033022
DOI:10.1097/ALN.0b013e3181d7b13a